首頁 › 第二型糖尿病 › 明尼蘇達 › Minneapolis
Minneapolis, MN 的 第二型糖尿病 臨床試驗
9 項針對 第二型糖尿病 的研究正在 Minneapolis（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
招募中3 期
- International Diabetes Center, Minneapolis
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
招募中3 期
- International Diabetes Center, Minneapolis
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
招募中歡迎健康志工
- Minneapolis Heart Institute Foundation, Minneapolis
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
招募中3 期
- Research Site, Minneapolis
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
招募中
- Health Partners, Minneapolis
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
招募中
- International Diabetes Center, Minneapolis
Individualized Diabetes Education Assisted by CGM (IDEA-CGM)
招募中
- University of Minnesota, Minneapolis
Glucose and Activity Tracking for Sedentary Behavior Interventions in Older People With Type 2 Diabetes (TRACK T2D)
招募中
- University of Minnesota, Minneapolis
Effectiveness of the Diabetes Homeless Medication Support (D-HOMES) Program on Diabetes Management
招募中
- Hennepin Healthcare Research Institute, Minneapolis
其他城市的 第二型糖尿病 試驗
- San Antonio, TX37 項研究
- Houston, TX31 項研究
- Orlando, FL24 項研究
- Boston, MA20 項研究
- Miami, FL19 項研究
- Chicago, IL19 項研究
- Dallas, TX19 項研究
- Columbus, OH18 項研究
- Las Vegas, NV18 項研究
- Atlanta, GA17 項研究
- San Diego, CA17 項研究
- Los Angeles, CA16 項研究
Minneapolis 的其他研究
- 乳癌27 項研究
- 非小細胞肺癌26 項研究
- 卵巢癌24 項研究
- 前列腺癌23 項研究
- 癌症（所有類型）22 項研究
- 心臟衰竭21 項研究
- 肺癌20 項研究
- 急性髓系白血病20 項研究
- 大腸直腸癌19 項研究
- 子宮內膜癌18 項研究
- 帕金森氏症17 項研究
- 心血管疾病15 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。